NPI: 1023326485 · TYLERTOWN, MS 39667 · Critical Access Hospital · NPI assigned 09/20/2010
Authorized official HESTER, BEN controls 20+ related entities in our dataset. Read more
| Authorized Official | HESTER, BEN (CFO) |
| Parent Organization | FORREST GENERAL HOSPITAL |
| NPI Enumeration Date | 09/20/2010 |
Other providers sharing the same authorized official: HESTER, BEN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,628 | $955K |
| 2019 | 23,089 | $1.10M |
| 2020 | 16,094 | $655K |
| 2021 | 20,145 | $789K |
| 2022 | 25,809 | $982K |
| 2023 | 24,286 | $1.02M |
| 2024 | 15,675 | $658K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,625 | 10,889 | $1.76M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,677 | 4,996 | $1.11M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,254 | 1,982 | $509K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,679 | 2,346 | $274K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,325 | 1,202 | $242K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,203 | 2,766 | $200K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,793 | 5,003 | $178K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,612 | 1,447 | $152K |
| 87634 | 3,198 | 2,763 | $144K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,651 | 1,501 | $143K |
| G0378 | Hospital observation service, per hour | 529 | 458 | $123K |
| 71046 | Radiologic examination, chest; 2 views | 2,708 | 2,367 | $121K |
| 71045 | Radiologic examination, chest; single view | 2,879 | 2,379 | $114K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3,191 | 2,754 | $107K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,086 | 430 | $92K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 691 | 348 | $75K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,754 | 1,550 | $73K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,123 | 2,492 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10,078 | 7,764 | $54K |
| 80053 | Comprehensive metabolic panel | 7,035 | 5,745 | $49K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,942 | 1,715 | $49K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,842 | 1,707 | $47K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,199 | 1,040 | $33K |
| 83880 | 1,421 | 1,219 | $30K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,326 | 1,171 | $29K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,145 | 1,974 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,799 | 2,316 | $23K |
| 87430 | 1,830 | 1,594 | $23K | |
| 81025 | 3,825 | 3,290 | $22K | |
| 74018 | 417 | 393 | $21K | |
| 84484 | 2,571 | 1,967 | $21K | |
| 82553 | 2,576 | 1,946 | $19K | |
| 36592 | 2,850 | 2,496 | $18K | |
| 73562 | 351 | 322 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,498 | 2,190 | $16K |
| 80061 | Lipid panel | 1,453 | 1,333 | $15K |
| 81001 | 6,597 | 5,762 | $15K | |
| A9270 | Non-covered item or service | 4,596 | 3,545 | $15K |
| 96361 | Intravenous infusion, hydration; each additional hour | 690 | 590 | $15K |
| 36415 | Collection of venous blood by venipuncture | 6,873 | 5,107 | $15K |
| 72100 | 170 | 155 | $12K | |
| 87081 | 1,620 | 1,415 | $12K | |
| 82550 | 3,193 | 2,019 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,415 | 1,310 | $10K |
| 87186 | 1,252 | 1,095 | $9K | |
| 87077 | 1,282 | 1,119 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 61 | 48 | $9K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 35 | 33 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 57 | 53 | $5K |
| 83735 | 562 | 387 | $3K | |
| 73630 | 60 | 53 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 13 | 12 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 40 | 40 | $2K |
| 73030 | 28 | 25 | $2K | |
| 82962 | 497 | 288 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 22 | 20 | $1K |
| 73502 | 24 | 24 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,920 | 2,284 | $1K |
| 82150 | 286 | 248 | $997.31 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 52 | 50 | $891.31 |
| 73610 | 14 | 14 | $828.81 | |
| 83605 | 111 | 93 | $707.18 | |
| 80305 | 128 | 115 | $688.08 | |
| 85730 | 150 | 145 | $677.76 | |
| 97032 | 49 | 12 | $672.39 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 878 | 736 | $646.20 |
| 85610 | 205 | 189 | $627.57 | |
| 82607 | 42 | 40 | $565.77 | |
| 87070 | 53 | 50 | $488.75 | |
| 74019 | 28 | 12 | $396.56 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,993 | 2,520 | $330.32 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,970 | 1,726 | $259.18 |
| 87205 | 67 | 62 | $213.92 | |
| 87420 | 18 | 16 | $203.35 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 15 | 14 | $191.22 |
| 84550 | 44 | 38 | $113.61 | |
| 94760 | 106 | 61 | $20.37 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 158 | 137 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 117 | 104 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 68 | 39 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 31 | 26 | $0.00 |